Phibro Animal Health (PAHC) Earning Favorable News Coverage, Study Shows

Media headlines about Phibro Animal Health (NASDAQ:PAHC) have been trending positive on Monday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Phibro Animal Health earned a news impact score of 0.30 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.4523251148487 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Phibro Animal Health (PAHC) traded down $0.10 during trading hours on Monday, reaching $35.45. 106,321 shares of the company’s stock traded hands, compared to its average volume of 79,201. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.75 and a current ratio of 3.12. The company has a market cap of $1,420.00, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 2.52 and a beta of 1.18. Phibro Animal Health has a 1 year low of $26.70 and a 1 year high of $40.25.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.06. The firm had revenue of $205.90 million for the quarter, compared to analysts’ expectations of $194.90 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The business’s quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter last year, the company posted $0.39 EPS. sell-side analysts forecast that Phibro Animal Health will post 1.69 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.13%. The ex-dividend date is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 25.97%.

Several brokerages have commented on PAHC. Credit Suisse Group raised their price target on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a report on Tuesday, February 6th. Morgan Stanley raised their price target on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a report on Wednesday, February 7th. Zacks Investment Research raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a report on Thursday. BidaskClub raised shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a report on Saturday, January 6th. Finally, ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Three analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $38.20.

ILLEGAL ACTIVITY WARNING: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.

Leave a Reply